Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 16.

Lewis, Thomas, Corcoran, David B., Thurston, David E., Giles, Peter J., Ashelford, Kevin, Walsby, Elisabeth J., Fegan, Christopher D., Pepper, Andrea G.S., Rahman, Khondaker Miraz and Pepper, Chris 2020. Novel pyrrolobenzodiazepine benzofused hybrid molecules inhibit NF-κB activity and synergise with bortezomib and ibrutinib in hematological cancers. Haematologica 10.3324/haematol.2019.238584

Elston, Lauren, Fegan, Chris, Hills, Robert, Hashimdeen, Shaikh S., Walsby, Elisabeth, Henley, Peter, Pepper, Chris and Man, Stephen 2020. Increased frequency of CD4+PD-1+HLA-DR+ T cells is associated with disease progression in CLL. British Journal of Haematology 188 (6) , pp. 872-880. 10.1111/bjh.16260

Pasikowska, Marta, Walsby, Elisabeth, Apollonio, Bendetta, Cuthill, Kirsty, Phillips, Elizabeth, Coulter, Eve, Longhi, Maria Serena, Ma, Yun, Yallop, Deborah, Barber, Linda D., Patten, Piers, Fegan, Chris, Ramsay, Alan G., Pepper, Chris, Devereux, Stephen and Buggins, Andrea G. S. 2016. Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration. Blood 128 (4) , pp. 563-573. 10.1182/blood-2016-01-683128

Pepper, C., Buggins, A. G.S., Jones, C. H., Walsby, E. J., Forconi, F., Pratt, G., Devereux, S., Stevenson, F. and Fegan, C. 2015. Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition. Leukemia 29 , pp. 744-747. 10.1038/leu.2014.308

Walsby, Elisabeth, Buggins, Andrea, Devereux, Stephen, Jones, Ceri, Pratt, Guy, Brennan, Paul, Fegan, Christopher and Pepper, Christopher 2014. Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia. Blood 123 (23) , pp. 3607-3617. 10.1182/blood-2013-12-544569

Walsby, Elisabeth Jane, Lazenby, Michelle, Pepper, Christopher John, Knapper, Steven and Burnett, Alan Kenneth 2013. The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells. British Journal of Haematology 161 (1) , pp. 57-67. 10.1111/bjh.12215

Walsby, Elisabeth Jane, Pearce, Laurence, Burnett, Alan Kenneth, Fegan, Christopher Daniel and Pepper, Christopher John 2012. The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells. Oncotarget 3 (5) , pp. 525-534.

Walsby, Elisabeth Jane, Coles, Steven, Knapper, Steven and Burnett, Alan Kenneth 2011. The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine. Haematologica 96 (3) , pp. 393-399. 10.3324/haematol.2010.032680

Walsby, Elisabeth Jane, Lazenby, Michelle, Pepper, Christopher John and Burnett, Alan Kenneth 2011. The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine. Leukemia 25 (3) , pp. 411-419. 10.1038/leu.2010.290

Pepper, Christopher John, Mahdi, J. G., Buggins, A. G. S., Hewamana, Saman, Walsby, Elisabeth Jane, Mahdi, Eamon, Al-Haza'a, A., Mahdi, Ali J., Lin, Thet Thet, Pearce, Laurence, Morgan, Liam David, Bowen, Ivor D., Brennan, Paul and Fegan, Christopher Daniel 2011. Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2. Cell Proliferation 44 (4) , pp. 380-390. 10.1111/j.1365-2184.2011.00760.x

Mehellou, Youcef, Valente, Rocco, Mottram, Huw James, Walsby, Elisabeth Jane, Mills, Kenneth Ian, Balzarini, Jan and McGuigan, Christopher 2010. Phosphoramidates of 2′-β-d-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism. Bioorganic & Medicinal Chemistry 18 (7) , pp. 2439-2446. 10.1016/j.bmc.2010.02.059

Walsby, Elisabeth Jane, Pratt, G., Hewamana, Saman, Crooks, P. A., Burnett, Alan Kenneth, Fegan, Christopher Daniel. and Pepper, Christopher John 2010. The NF- B inhibitor LC-1 has single agent activity in multiple myeloma cells and synergizes with bortezomib. Molecular Cancer Therapeutics 9 (6) , pp. 1574-1582. 10.1158/1535-7163.MCT-10-0104

Al Shaer, Laila, Walsby, Elisabeth Jane, Gilkes, Amanda F., Tonks, Amanda Jayne, Walsh, Valerie, Mills, Kenneth Ian, Burnett, Alan Kenneth and Rowntree, Clare 2008. Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling. British Journal of Haematology 141 (4) , pp. 483-493. 10.1111/j.1365-2141.2008.07053.x

Walsby, Elisabeth Jane, Walsh, Val, Pepper, Christopher John, Burnett, Alan Kenneth and Mills, Ken 2008. Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts. Haematologica 93 (5) , pp. 662-669. 10.3324/haematol.12148

Walsby, Elisabeth Jane, Gilkes, Amanda Frances, Tonks, Alex, Darley, Richard Lawrence and Mills, Kenneth Ian 2007. FUS expression alters the differentiation response to all-trans retinoic acid in NB4 and NB4R2 cells. British Journal of Haematology 139 (1) , pp. 94-97. 10.1111/j.1365-2141.2007.06756.x

Walsby, Elisabeth Jane 2004. Role of FUS (TLS) in differentiation in acute myeloid leukaemia. PhD Thesis, Cardiff University.

This list was generated on Thu Oct 29 07:08:33 2020 GMT.